-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Enanta Pharmaceuticals Inc annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2012 to Q4 2023.
- Enanta Pharmaceuticals Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$25M, a 29.9% increase year-over-year.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$78.8M, a 23.6% increase from 2023.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$103M, a 21.7% decline from 2022.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$84.8M, a 21.1% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)